03.02.2023 - BOSTON, Feb. 03, 2023 (GLOBE NEWSWIRE) - Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the company is scheduled to participate in fireside .